Literature DB >> 3348159

Vitamin K deficiency from dietary vitamin K restriction in humans.

J W Suttie1, L L Mummah-Schendel, D V Shah, B J Lyle, J L Greger.   

Abstract

Vitamin K is required for the maintenance of normal hemostatic function. Ten college-aged male subjects chose diets restricted in vitamin K content for 40 d. Median phylloquinone intakes based on analysis of food composites dropped from 82 micrograms/d during the prestudy period to 40 and 32 micrograms/d at d 9 and 27 of dietary restriction, respectively. Serum phylloquinone concentrations fell from a mean of 0.87 to 0.46 ng/mL during a 21-d period of vitamin K restriction. Supplementation with 50 micrograms phylloquinone/d for 12 d increased serum phylloquinone to 0.56 ng/mL, and supplementation with 500 micrograms phylloquinone/d increased serum phylloquinone to 1.66 ng/mL. Vitamin K restriction resulted in alterations in a functional clotting assay that detects undercarboxylated prothrombin species in plasma and in a decrease in urinary gamma-carboxyglutamic acid. Supplementation with either 50 or 500 micrograms of phylloquinone restored both these indices to near normal values. These data are consistent with a human dietary vitamin K requirement of approximately 1 microgram/kg body wt/d.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348159     DOI: 10.1093/ajcn/47.3.475

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  13 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Quantitation of vitamin K in human milk.

Authors:  L M Canfield; J M Hopkinson; A F Lima; G S Martin; K Sugimoto; J Burr; L Clark; D L McGee
Journal:  Lipids       Date:  1990-07       Impact factor: 1.880

3.  Vitamin K and metabolic bone disease.

Authors:  C Vermeer; M H Knapen; L J Schurgers
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

Review 4.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

Review 5.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

6.  Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole.

Authors:  Jeannine Chan; Tyler Oshiro; Sarah Thomas; Allyson Higa; Stephen Black; Aleksandar Todorovic; Fawzy Elbarbry; John P Harrelson
Journal:  Drug Metab Dispos       Date:  2016-02-05       Impact factor: 3.922

7.  Dietary Vitamin K and Association with Hepatic Vitamin K Status in a Yup'ik Study Population from Southwestern Alaska.

Authors:  Nicholas T Au; Tove Ryman; Allan E Rettie; Scarlett E Hopkins; Bert B Boyer; Jynene Black; Jacques Philip; Joseph Yracheta; Alison E Fohner; Morayma Reyes; Timothy A Thornton; Melissa A Austin; Kenneth E Thummel
Journal:  Mol Nutr Food Res       Date:  2017-12-29       Impact factor: 5.914

Review 8.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

9.  Dietary induced subclinical vitamin K deficiency in normal human subjects.

Authors:  G Ferland; J A Sadowski; M E O'Brien
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 10.  Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review.

Authors:  Molly W Mandernach; Rebecca J Beyth; Anita Rajasekhar
Journal:  Ther Clin Risk Manag       Date:  2015-08-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.